Berkers CR - Search Results

1

Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.

Groll M, Berkers CR, Ploegh HL, Ovaa H. Groll M, et al. Among authors: berkers cr. Structure. 2006 Mar;14(3):451-6. doi: 10.1016/j.str.2005.11.019. Structure. 2006. PMID: 16531229 Free article.

2

Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib.

Berkers CR, Verdoes M, Lichtman E, Fiebiger E, Kessler BM, Anderson KC, Ploegh HL, Ovaa H, Galardy PJ. Berkers CR, et al. Nat Methods. 2005 May;2(5):357-62. doi: 10.1038/nmeth759. Epub 2005 Apr 21. Nat Methods. 2005. PMID: 15846363

3

Drug discovery and assay development in the ubiquitin-proteasome system.

Berkers CR, Ovaa H. Berkers CR, et al. Biochem Soc Trans. 2010 Feb;38(Pt 1):14-20. doi: 10.1042/BST0380014. Biochem Soc Trans. 2010. PMID: 20074028

4

Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells.

Kraus M, Rückrich T, Reich M, Gogel J, Beck A, Kammer W, Berkers CR, Burg D, Overkleeft H, Ovaa H, Driessen C. Kraus M, et al. Among authors: berkers cr. Leukemia. 2007 Jan;21(1):84-92. doi: 10.1038/sj.leu.2404414. Epub 2006 Oct 5. Leukemia. 2007. PMID: 17024115

5

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.

Chauhan D, Catley L, Li G, Podar K, Hideshima T, Velankar M, Mitsiades C, Mitsiades N, Yasui H, Letai A, Ovaa H, Berkers C, Nicholson B, Chao TH, Neuteboom ST, Richardson P, Palladino MA, Anderson KC. Chauhan D, et al. Cancer Cell. 2005 Nov;8(5):407-19. doi: 10.1016/j.ccr.2005.10.013. Cancer Cell. 2005. PMID: 16286248 Free article.

6

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.

Piva R, Ruggeri B, Williams M, Costa G, Tamagno I, Ferrero D, Giai V, Coscia M, Peola S, Massaia M, Pezzoni G, Allievi C, Pescalli N, Cassin M, di Giovine S, Nicoli P, de Feudis P, Strepponi I, Roato I, Ferracini R, Bussolati B, Camussi G, Jones-Bolin S, Hunter K, Zhao H, Neri A, Palumbo A, Berkers C, Ovaa H, Bernareggi A, Inghirami G. Piva R, et al. Blood. 2008 Mar 1;111(5):2765-75. doi: 10.1182/blood-2007-07-100651. Epub 2007 Dec 5. Blood. 2008. PMID: 18057228 Free article.

7

Chemical proteomics profiling of proteasome activity.

Verdoes M, Berkers CR, Florea BI, van Swieten PF, Overkleeft HS, Ovaa H. Verdoes M, et al. Among authors: berkers cr. Methods Mol Biol. 2006;328:51-69. doi: 10.1385/1-59745-026-X:51. Methods Mol Biol. 2006. PMID: 16785641

8

Fluorescence-based proteasome activity profiling.

de Jong A, Schuurman KG, Rodenko B, Ovaa H, Berkers CR. de Jong A, et al. Among authors: berkers cr. Methods Mol Biol. 2012;803:183-204. doi: 10.1007/978-1-61779-364-6_13. Methods Mol Biol. 2012. PMID: 22065226

9

Probing the specificity and activity profiles of the proteasome inhibitors bortezomib and delanzomib.

Berkers CR, Leestemaker Y, Schuurman KG, Ruggeri B, Jones-Bolin S, Williams M, Ovaa H. Berkers CR, et al. Mol Pharm. 2012 May 7;9(5):1126-35. doi: 10.1021/mp2004143. Epub 2012 Apr 16. Mol Pharm. 2012. PMID: 22432738

10

Profiling proteasome activity in tissue with fluorescent probes.

Berkers CR, van Leeuwen FW, Groothuis TA, Peperzak V, van Tilburg EW, Borst J, Neefjes JJ, Ovaa H. Berkers CR, et al. Mol Pharm. 2007 Sep-Oct;4(5):739-48. doi: 10.1021/mp0700256. Epub 2007 Aug 21. Mol Pharm. 2007. PMID: 17708652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters